IL6 and COVID-19: Although insulin has been shown to exhibit anti-inflammatory action [17], it remains to be seen whether this is true for COVID-19 patients or contrary to that IL-6 increases insulin resistance [24], and hence its anti-inflammatory effects are overcome [25].